Clinical Research
Copyright ©The Author(s) 2004.
World J Gastroenterol. Dec 1, 2004; 10(23): 3500-3505
Published online Dec 1, 2004. doi: 10.3748/wjg.v10.i23.3500
Table 3 Effect of Kangfeidian No.1,2, 3 with Western medicine in SARS patients
Outcome measureKangfeidian No.1, 2, 3 combined with Western medicineWestern medicine aloneRelative risk (95%CI)PReference
Mortality(n/N)
4/314/321.04 (0.24, 4.57)Zhang XM et al
0/371/390.34 (0.01, 8.67)(2003)
Overall4/685/710.86 (0.22, 3.29)0.82
Lung infiltrate27/3118/325.25 (1.49, 18.53)Zhao CH et al
Absorbing22/376/398.07 (2.71, 23.98)(2003)
Overall49/6824/716.68 (2.93, 15.24)<0.00001Zhao CH et al
The averageN (mean ± SD)WMD(95%CI)(2003)
Dosage of
Glucocrticosteroids31 (304.13 ± 143.42)32 (347.40 ± 173.10)-43.2 7(-121.67, 35.13)Zhang XM et al
15 (1400.00 ± 685.00)20 (1325.00 ± 623.00)75.00 (-366.27, 516.27)(2003)
Zhao CH et al
(2003)
Overall4652-39.65 (-116.84, 37.54)0.31